AprilBio

At a glance

AprilBio filed 76 disclosures in the last 12 months, including 25 insider, 8 5% holder and 3 issuance. The most recent key filing was on Oct 23: A major holder's stake rose from 41.30% to 41.30%.

The 2025 annual report lists 27 employees with an average tenure of 3.7 years and average pay of ₩201.1M. Its 4 directors and auditors were paid ₩153M each on average. It paid no cash dividend for 2025. 차상훈 and related parties held 19.57% at year end.

Of 1 recent 5%+ holder report, 0 raised and 0 cut a stake; the largest stake reported was 41.30% on Oct 23.

From the 2025 annual report

Staff: 27 (12 men, 15 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩5.4B. Directors and auditors: 4, paid ₩612M in total.

No cash dividend was paid for 2025.

Largest shareholder

차상훈 holds 19.07%; with 2 related parties the group holds 19.57% of common shares at year end (from 20.33% at the start of the year).

Individuals paid ₩500M or more

Auditor: 성현회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports